Dalit Talmi-Frank

Dalit Talmi-Frank currently serves as Principal Scientist in Translational Biomarkers at Zoetis, leading translational medicine efforts across oncology, cardiovascular, and dermatology therapeutic areas since February 2021. Previously, Talmi-Frank held positions as Principal Scientist and Head of In Vivo Pharmacology at Zoetis, focusing on developing therapeutics for infectious diseases, and managing projects at Colorado State University to explore bat immune mechanisms. Academic experience includes postdoctoral research at the Weizmann Institute of Science and a PhD from the Hebrew University of Jerusalem, specializing in infectious diseases and vector-borne diseases. Additionally, Talmi-Frank completed a DVM at the Koret School of Veterinary Medicine, with early training in a clinical internship focused on critical care medicine.